Second Opinion International

Second Opinion International is a healthcare services and digital health company focused on remote medical second-opinion services rather than drug development. Public company-profile sources describe it as operating an international network of virtual clinics that connects patients and subscribers with leading hospitals and specialists for independent review of diagnoses and treatment plans. Its flagship offering is a medical second-opinion service delivered through subscriber-centered interactive medical systems. The company appears to focus on cross-border medical consultation and care-navigation support across multiple specialties rather than therapeutics R&D. No evidence of a drug pipeline, clinical-stage assets, or proprietary therapeutic products was identified in available public sources.